Druckansicht der Internetadresse:


Chair of Food Law | Prof Dr Kai Purnhagen LLM

Print page


New project: “An analysis of the regulatory environment applicable to products obtained from mushrooms and fungal mycelium”Hide

In a world advancing steadily towards sustainability, meat and dairy industry are losing the narrative in the fight against the innovative food industry because of their huge environmental impact. In the landscape of food innovation, mushrooms-derived product are becoming increasingly popular since they can substitute protein of animal origin in several food products and be used as additives, processing aids, food supplements and traditional medicines.

Investment in mushroom-derived products is likely to increase and we expect that different national, federal or supranational regulatory frameworks will be in competition to best enable such innovative products. While it is generally acknowledged that regulation can facilitate innovation, a number of scholars argue that the regulatory design may also function as an obstacle to innovation, particularly in the food sector. Considering the pivotal role that a clear and predictable regulatory environment can play, the regulatory framework for the marketing of innovative foods will play a vital role in making the European Union a catalyst in the transformation of the food world.

This project constitutes a comprehensive analysis on how the EU legal system governs food innovations related to mushrooms, mushroom-derived products and fungal mycelium, and on how these products can be legally marketed in the EU.”

New project: "Deciding on 'Benefits' of emerging technologies under international and European law ­­- The case of CRISPR: A law in context approach" Hide

We are excited to announce the start of our new project here at the Chair of Food Law, Campus Kulmbach, University Bayreuth, in cooperation with the Federal Office of Consumer Protection and Food Safety (BVL), the Hasso Plattner Institute in Potsdam and Stanford University.

The CRISPR technology is new and risks remain unclear for certain applications. At the same time the potential benefits are enormous. This research project is innovative  in that it is the first to propose a comprehensive insight into the concept of 'benefits' that lies beyond the traditional  risk-based regulatory mechanisms. The project seeks to generate an understanding of the benefits of new technologies in biosciences under EU law and provide arguments that could be used in CRISPR regulation.

Webmaster: Helena Singer

Twitter Youtube-Kanal UBT-A Contact